Who is moving to which position
Resolved 27 March 2026Incoming appointee
1 itemDeparting officer
1 item“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Continuing in office as Director
| Item | Details |
|---|---|
| Resolution date | 27 March 2026 |
| Scheduled Appointment Date | The date of the annual general meeting of shareholders for the 118th fiscal period, scheduled for June 2026 (the Representative Director and directors with titles are scheduled to be selected at the Board of Directors meeting following the general meeting) |
| Date of departure | The date of the annual general meeting of shareholders for the 118th fiscal period, scheduled for June 2026 (scheduled to cease serving as Chairman of the Board and CEO) |
| Name of appointee | Takeda Genya (竹田玄哉) |
| Appointee's new position | Representative Director, President and CEO |
| Appointee's previous position | Representative Director, President and COO |
| Name of departing officer | Takeda Yozo (竹田陽三) |
| Former position of departing officer | Representative Director, Chairman of the Board and CEO |
| New position of departing officer | Director and Special Advisor |
| Whether the incumbent will remain in office | Continuing in office as Director |
| Number of directors after the change | 9 directors (including 5 outside directors) |
| Filing as an independent officer | The company plans to register Kaneko Motohisa (金子素久), Morichi Takafumi (森地高文), Iriyama Akie (入山章栄), Izawa Nobuyuki (井澤囊幸) and Tomioka Sayaka (富岡さやか) as independent officers |
| Subject to Approval by the General Meeting of Shareholders | Required. Proposal for the election of 9 directors and 1 Audit & Supervisory Board member at the annual general meeting of shareholders for the 118th fiscal period, scheduled for June 2026 |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No specific explanation is provided for the changes in directors and Audit & Supervisory Board members.